Stock Events

Stock Events

Compass Pathways 

€7.9
308
+€0+0% Today

Statistics

Day High
7.95
Day Low
7.8
52W High
8.15
52W Low
2.12
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5Y6.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AtaiBeckley
ATAI
Mkt Cap1.52B
ATAI Life Sciences works on developing psychedelic and non-psychedelic compounds for mental health, a direct competitor in the psychedelic medicine field.
GH Research
GHRS
Mkt Cap1.42B
GH Research is focused on developing 5-MeO-DMT therapies for mental health disorders, competing in the same therapeutic area as Compass Pathways.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, competing with Compass Pathways in the psychedelic mental health treatment market.
SPDR SSGA My2035 Corporate Bond
MYCO
Mkt Cap0
Mydecine Innovations Group is engaged in the development of psychedelic medicines, competing in the same space as Compass Pathways.
Revive Therapeutics
RVVTF
Mkt Cap11.33M
Revive Therapeutics is exploring the use of psychedelics for the treatment of mental illness and addiction, making it a competitor in the psychedelic therapy market.

About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Show more...
CEO
Mr. Kabir Kumar Nath M.A., M.B.A.
Employees
156
Country
United Kingdom
ISIN
US20451W1018

Listings

MX
MX
CMPSN.MX
F
DE
5Y6.F
STU
DE
5Y6.STU
MU
DE
5Y6.MU

0 Comments

Share your thoughts

FAQ

What is Compass Pathways stock price today?▼
The current price of 5Y6.STU is €7.9 EUR — it has increased by +0% in the past 24 hours. Watch Compass Pathways stock price performance more closely on the chart.
What is Compass Pathways stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Compass Pathways stocks are traded under the ticker 5Y6.STU.
Is Compass Pathways stock price growing?▼
5Y6.STU stock has risen by +9.03% compared to the previous week, the month change is a +58.27% rise, over the last year Compass Pathways has showed a +135.03% increase.
How many employees does Compass Pathways have?▼
As of May 06, 2026, the company has 156 employees.
In which sector is Compass Pathways located?▼
Compass Pathways operates in the Health & Wellness sector.
When did Compass Pathways complete a stock split?▼
Compass Pathways has not had any recent stock splits.
Where is Compass Pathways headquartered?▼
Compass Pathways is headquartered in London, United Kingdom.